Loading company…
OncoMed Pharmaceuticals develops investigational cancer therapies, including monoclonal antibodies targeting cancer stem cells.
OncoMed Pharmaceuticals develops investigational therapies designed to target cancer stem cells and affect cancer cell growth and survival. Founded in 2004, the company is based in Redwood City, US. In July 2013, it raised USD 82 million in an IPO, selling 4.8 million shares at USD 17 per share.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in